Jie He

FDA investigator

Appears on 6 documents from 2023 to 2025, most often at sites in North Carolina. Most often cites written procedures; deviations (21 CFR 211.100).

6
Documents on file
4.5
Observations per 483
2023
First seen
2025
Most recent

What they cite most

From 27 observations

Activity by year

2023: 2, 2024: 2, 2025: 2

Where

North Carolina 2 · Ireland 1 · Massachusetts 1 · Texas 1

Is Jie He coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Fujifil m Diosyn th Biotechnologies Texas, LLCMar 11, 2025 · College Station, Texas
483 Allergan Pharmaceuticals Ireland UnlimitedJan 30, 2025 · Westport, Ireland
483 FDA Form 483 Lonza Netherlands BV, Geleen, Netherlands, July 2024Jul 12, 2024
483 RTP Operating, LLCFeb 16, 2024 · Durham, North Carolina
483 FDA Form 483 Pfizer, Sanford, NC Nov 2023Nov 10, 2023 · Sanford, North Carolina
483 Berkshire Sterile Manufacturing (BSM)Jan 20, 2023 · Lee, Massachusetts

About this profile

What does Jie He inspect?

Jie He appears on 6 documents on file covering 6 sites, most often in North Carolina.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jie He is dated Mar 11, 2025.

FDA Investigator Jie He: 483s & Inspections · FDA Intel